Free Trial

Corcept Therapeutics (CORT) SEC Filings & 10K Form

Corcept Therapeutics logo
$56.68 -0.43 (-0.75%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$58.38 +1.70 (+2.99%)
As of 03/27/2025 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Corcept Therapeutics SEC Filings

DateFilerForm TypeView
03/26/2025
5:55 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
7:30 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:30 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:54 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
10:02 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:15 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:53 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:58 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:34 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:38 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:59 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:47 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:37 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:18 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:18 PM
Corcept Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
3:06 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:23 PM
Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:08 PM
BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
3:40 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2025
7:20 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:26 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
10:36 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:33 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:17 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
3:14 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
7:20 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
6:30 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
9:49 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
6:59 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:15 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:24 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:03 PM
BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
11:03 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
10:52 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
10:58 AM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:41 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:20 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Dirty Secret About Gold Mining Stocks... (Ad)

Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy shareholder value over time. Even as gold prices rise.

Right now, I've found 4 miners showing the exact same pattern as previous 100-baggers.
12/12/2024
3:59 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
9:00 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:13 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
5:16 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
1:36 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
10:41 AM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:06 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:48 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
11:55 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/30/2024
3:09 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:12 PM
Corcept Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/03/2024
3:27 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
6:55 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
11:55 AM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
11:44 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2024
5:34 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:27 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:24 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:57 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:04 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
7:08 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
10:33 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
4:59 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
2:37 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
6:10 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:31 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:56 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
3:42 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
12:36 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
10:26 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
3:13 PM
Corcept Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/03/2024
4:13 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:16 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:54 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:54 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
12:54 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
12:46 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
12:30 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
9:16 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
5:47 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:21 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:19 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:10 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:11 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:13 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:15 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:15 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
1:15 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
1:05 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:05 PM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
05/31/2024
3:38 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:38 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:38 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:39 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:40 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:41 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:43 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:44 PM
Corcept Therapeutics (Filer)
Form S-8 POS
05/31/2024
3:45 PM
Corcept Therapeutics (Filer)
Form S-8 POS
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CORT) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners